Harlan M. Krumholz

Nov 2, 2024 | sciencedirect.com | Behnood Bikdeli |Harlan M. Krumholz

“Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models”: comment • None Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models • None Venous lactate improves the prediction of in-hospital adverse outcomes in normotensive pulmonary embolism • None Short-term clinical outcome of normotensive patients with acute PE and...

Oct 29, 2024 | nature.com | Olalekan Lee Aiyegbusi |Alastair K Denniston |Rosie Harding |Sarah Hughes |Dipak Kotecha |Harlan M. Krumholz | +3 more

AbstractDecentralized clinical trials involving the use of digital tools to facilitate remote research are gaining momentum. Rapid advancements in digital technologies have supported the adoption of these trials. These innovations facilitate virtual interactions between clinical trial teams and participants by making it easier to collect, transfer and store electronic data.

Oct 1, 2024 | medrxiv.org | Adith Arun |Harlan M. Krumholz

HMK reports receiving options for Element Science and Identifeye and payments from F-Prime for advisory roles; being a cofounder of and holding equity in Hugo Health, Refactor Health, and Ensight-AI; and being associated with research contracts through Yale University from Janssen, Kenvue, Novartis, and Pfizer. No other disclosures were reported.

Aug 30, 2024 | healio.com | Erik Swain |Richard Smith |Harlan M. Krumholz |Benjamin M. Scirica

Harlan M. Krumholz, MD, SM, FACC Studies like this one indicate to us that this is not just about weight loss. This is really about promotion of health. What we are finding is that these drugs are having a dramatic impact on cardiovascular health, and I speculate that this sort of marked improvement in cardiometabolic health is somehow protecting people when they’re in a position where they need to defend themselves against something like a novel virus. This is an amazing study.

Aug 26, 2024 | medrxiv.org | Evangelos Oikonomou |Sumukh Vasisht Shankar |Andreas C. Coppi |Harlan M. Krumholz

R.K. is an Associate Editor of JAMA and receives research support, through Yale, from the Blavatnik Foundation, Bristol-Myers Squibb, Novo Nordisk, and BridgeBio. He is a coinventor of U.S. Provisional Patent Applications 63/177,117, 63/428,569, 63/346,610, 63/484,426, 63/508,315, 63/580,137, 63/606,203, 63/562,335, 18/813,882, and a co-founder of Ensight-AI, Inc and Evidence2Health, LLC.